MarketScreener Strategies Cytokinetics, Incorporated
Stocks
CYTK
US23282W6057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.18 USD | -0.22% |
|
-5.53% | +26.19% |
| 07-14 | Cytokinetics Insider Sold Shares Worth $615,150, According to a Recent SEC Filing | MT |
| 07-07 | RBC Capital Adjusts Cytokinetics Price Target to $117 From $119, Maintains Outperform Rating | MT |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- CYTK Stock
- News Cytokinetics, Incorporated
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition